Walleye Capital LLC Natera, Inc. Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$97.75 - $129.67 $869,975 - $1.15 Million	8,900 Added 2225.0%	9,300 $1.18 Million
Q2 2024 Aug 14, 2024	BUY	$85.28 - $112.6 $34,112 - $45,040	400 New	400 $43,000
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $41,305 - $68,904	-1,100 Reduced 91.67%	100 $6,000
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $52,080 - $75,024	1,200 New	1,200 $53,000
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $136,680 - $191,640	4,000 Added 4000.0%	4,100 $164,000
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $3,693 - $5,668	100 New	100 $4,000
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $212,421 - $494,091	-12,300 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $394,830 - $496,920	12,300 New	12,300 $414,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.